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Abstract
Background: Recurrent airway obstruction (RAO) in horses is a naturally occurring dust-induced disease mainly
characterized by bronchiolitis which shows histological and pathophysiological similarities to human chronic
obstructive pulmonary disease (COPD). In human COPD previous investigations indicated an association with
Chlamydophila psittaci infection. The present study was designed (1) to clarify a possible role of this infectious agent
in RAO and (2) to investigate the suitability of this equine disorder as a model for human COPD.
Methods: Clinico-pathological parameters of a total of 45 horses (25 horses with clinical signs of RAO and 20
clinically healthy controls) were compared to histological findings in lung tissue samples and infection by
Chlamydiaceae using light microscopy, immunohistochemistry, and PCR.
Results: Horses with clinical signs of RAO vs. controls revealed more inflammatory changes in histology (p =
0.01), and a higher detection rate of Chlamydia psittaci antigens in all cells (p < 0.001) and bronchiolar epithelial
cells alone (p < 0.001) by immunohistochemistry. The abundance of chlamydial inclusions increased with the
severity of disease. PCR was positive in 60% of horses with RAO vs. 45% of the controls (p = 0.316). OmpA
sequencing identified Chlamydophila psittaci (n = 9) and Chlamydophila abortus (n = 13) in both groups with no
significant differences. Within the group of clinically healthy horses subgroups with no changes (n = 15) and slight
inflammation of the small airways (n = 5) were identified. Also in the group of animals with RAO subgroups with
slight (n = 16) and severe (n = 9) bronchiolitis could be formed. These four subgroups can be separated in parts
by the number of cells positive for Chlamydia psittaci antigens.
Conclusion: Chlamydophila psittaci or abortus were present in the lung of both clinically healthy horses and those
with RAO. Immunohistochemistry revealed acute chlamydial infections with inflammation in RAO horses,
whereas in clinically healthy animals mostly persistent chlamydial infection and no inflammatory reactions were
seen. Stable dust as the known fundamental abiotic factor in RAO is comparable to smoking in human disease.
These results show that RAO can be used as a model for human COPD.
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Background
Recurrent Airway Obstruction (RAO) in horses, formerly
called equine chronic obstructive pulmonary disease
(COPD), is a very common illness [1]. Pathology is char-
acterized by bronchiolitis [2,3], which is similar to find-
ings in human COPD and advanced human pulmonary
emphysema [4]. Organic dust exposure and endotoxin are
relevant factors for chronic impairment of lung function
in horses and are used in experimental animal studies to
cause exacerbations [5,6].
Our own group detected Chlamydophila psittaci (CPP)
infection by PCR in 38% of human patients with COPD
[7,8], who were suffering from advanced pulmonary
emphysema and underwent lung volume reduction sur-
gery. Chlamydial antigens were shown in alveolar paren-
chyma and bronchioles. CPP  and also Chlamydophila
abortus (CPA) was detected in sputum samples from
patients with exacerbations of COPD as well [9]. Up to
now,  Chlamydophila  spp. have been rarely detected in
horses with acute respiratory infections [10,11]. Mair and
Wills [12] found culturable chlamydiae in 5% of equine
nasal and conjunctival swabs in a prevalence study, but no
association between isolation and clinical diseases was
seen. However, these low detection rates in the pre-PCR
era may have been due to the known difficulties of cultur-
ing these obligate intracellular bacteria. Serologically anti-
body titres ≥ 32 against Chlamydophila pneumoniae (CPPN)
were detected in 26.5% of Italian light horses. Some sera
with high titres reacted weakly with CPP as well [13]. But
within aborted equine fetuses CPP has been found in high
prevalence [14,15]
In the present study lung tissue samples from horses with
RAO as well as a group of clinically healthy horses were
examined by immunohistochemistry, immunofluores-
cence and PCR to assess the extent of chlamydial infection
and its association with RAO. PCR positive samples were
additionally evaluated by DNA sequencing to define
exactly the chlamydial species involved.
Methods
Samples
Out of 948 horses, which were slaughtered or euthanized
in the period between November 2002 and October 2004
in three western districts of Westphalia, 26 horses were
identified as possibly suffering from RAO by questioning
veterinarians and/or horse owners about reasons for
slaughter or euthanasia. Slaughter was done according to
federal law in authorized slaughterhouses and under con-
trol of a veterinarian. Euthanasia was practised by veteri-
narians following internationally recognized guidelines.
If the horses had shown respiratory disease history, symp-
toms and therapy as well as conditions of housing were
evaluated in detail by using a standardized questionnaire,
which is available as online addendum. Possible RAO and
control horses were clinically examined before slaughter
or euthanasia. The horses had to meet the following crite-
ria [Additional file 1]: (1) chronic cough for at least 3
months duration; (2) exercise intolerance; (3) worsening
of the symptoms due to dust; (4) obvious biphasic expir-
atory dyspnoea with hypertrophy of Mm. recti abdomini,
inflated nostrils and nasal discharge; (5) breathing fre-
quency > 20/min; and (6) pathologic findings in lung aus-
cultation. As respiratory healthy controls served 20 horses
which completely lacked these clinical criteria. Immedi-
ately after death, tissue was taken from 8 different lung
regions of each horse and preserved for the following
examinations.
Light Microscopic Histology
Formalin-fixed lung tissue was embedded in paraffin wax
(Tissuewax™; Medite GmbH, Burgdorf, Germany), slices
of 3–7 μm thickness were cut using a rotatory microtome
(Microm GmbH, Walldorf, Germany), and stained with
haematoxylin and eosin. Slices from the 8 tissue samples
of each horse were evaluated for histological changes
using a semi-quantitative score (0–4) in a blinded study.
No signs of bronchiolitis were scored with 0 points. Min-
imal infiltration of the bronchioli with lymphocytes was
scored with 1, slight inflammation with 2, moderate
bronchiolitis with some neutrophils with 3, and severe
changes with intraluminal aggregates of neutrophils with
4 points. Results from all 8 regions of each horse were
added. Therefore a minimal score of 0 and a maximal
score of 32 was possible.
One horse with RAO-like respiratory symptoms and his-
tory revealed parasitic lung disease after histological inves-
tigation and was excluded therefore.
According to anamnesis, clinical findings and light micro-
scopy, the remaining 45 horses were classified into four
subgroups:
I. Clinically healthy horses without histological changes
of RAO (n = 15),
II. Clinically healthy horses with a low inflammation
score of 4–6 (n = 5),
III. Horses with clinical signs of RAO, but without or with
only slight histological changes and a score of 0–5 (n =
16), and
IV. Horses with symptoms and histological changes of
RAO with a score > 10 (n = 9).Respiratory Research 2008, 9:14 http://respiratory-research.com/content/9/1/14
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Immunohistochemistry and Immunofluorescence
For immunohistochemistry, dewaxed slices were stained
with a mouse anti-CP primary antibody (Biotrend, Ger-
many; clone 73/0200, dilution 1:60) for 2 hours at room
temperature, followed by a peroxidase-based detection
system (Histostain®-Bulk-Kit, Zymed Laboratories Inc.,
San Francisco, USA) according to the instructions of the
manufacturer). Three high-power fields showing bronchi-
oli were selected for counting all detectable vs. all CP-pos-
itive stained bronchiolar epithelial cells (BEC), type II
pneumocytes (PII) and macrophages (MP) separately,
using a Zeiss Axiophot microscope (Carl Zeiss, Oberko-
chen, Germany) with a 40-fold objective magnification
and a digital imaging system (Diskus Software, Koenig-
swinter, Germany). For immunofluorescence, triple stain-
ing on dewaxed sections was done with a primary mouse
monoclonal IgG2b-antibody against CP  (Biotrend, Ger-
many; clone 73/0200, dilution 1:100) and a primary
mouse monoclonal IgG1-antibody mix against pan-cytok-
eratin (BioCarta, USA; clones AE1, AE3, 5D3, dilution
1:50), as well as 4',6-diamidino-2-phenylindol-hydro-
chloride (DAPI, Sigma, Germany, working concentration
0.1  μg/ml). Alexa Fluor 488-conjugates of goat anti-
mouse-IgG1 (dilution 1:400), and Alexa Fluor 594-conju-
gates of goat anti-mouse-IgG2b (dilution 1:400) were used
as secondary antibodies (Molecular Probes Europe, Lei-
den, The Netherlands). Results were documented with a
CCD-camera (Kappa, Gleichen, Germany) attached to an
Olympus IX-70 microscope (Olympus Europe, Hamburg,
Germany) with 40-fold objective magnification.
Polymerase Chain Reaction (PCR)
Lung tissue was collected immediately after slaughtering/
euthanizing of the horses and stored at -80°C. DNA was
isolated from lung tissue using the High Pure PCR Tem-
plate Preparation Kit (Roche Diagnostics, Mannheim,
Germany) according to the instructions of the manufac-
turer. 5 μl of the DNA extract were used as template in
PCR. Samples were tested for CPP/CPA and CPPN by a
modified version of the nested PCR procedure described
by Kaltenboeck et al. [16] which targets the ompA gene.
The first step was genus-specific amplification using prim-
ers 191CHOMP (5'-GCI YTI TGG GAR TGY GGI TGY GCI
AC-3') and CHOMP371 (5'-TTA GAA ICK GAA TTG IGC
RTT IAY GTG IGC IGC-3'). For the second amplification,
we used 1 μl of the genus-specific product and primer
combination 218PSITT (5'-GTA ATT TCI AGC CCA GCA
CAA TTY GTG-3')/CHOMP336s (5'-CCR CAA GMT TTT
CTR GAY TTC AWY TTG TTR AT-3') for CP, or
201CHOMP (5'-GGI GCW GMI TTC CAA TAY GCI CAR
TC-3')/PNEUM268 (5'-GTA CTC CAA TGT ATG GCA CTA
AAG A-3'), for CPPN, respectively. The sizes of specific
amplicons are: 576–597 bp (genus-specific product), and
389–404 bp for CP, or 244 bp for CPPN after nested PCR.
A detailed protocol of the procedure was previously pub-
lished by Sachse and Hotzel [17] and is given here:
A. Genus-Specific Detection of Chlamydiae
Prepare a master mix of reagents for all amplification reac-
tions of the series. It should contain the following ingre-
dients per 50-μl reaction:
1 μl dNTP mix (2 mM each), 1 μl primer 191CHOMP (20
pmol/μl), 1 μl primer CHOMP371 (20 pmol/μl), 5 μl
reaction buffer (10×), 0.2 μl Taq DNA polymerase (5 U/
μl), 40.8 μl H2O. Add template to each reaction vessel: 1
μl of DNA extract from infected tissue or 5 μl of extract
from swab samples. Include amplification controls: DNA
of a chlamydial reference strain (positive control) and
water (negative control 1) instead of sample extract. Run
PCR according to the following temperature-time profile:
Initial denaturation at 95°C for 30 s, 35 cycles of denatur-
ation (95°C for 30 s), primer annealing (50°C for 30 s)
and primer extension (72°C for 30 s). Correct amplifica-
tion leads to the formation of a 576–597-bp product spe-
cific for the genus Chlamydia  (according to the new
taxonomy: Chlamydia and Chlamydophila).
B. Species-Specific Detection of Chlamydiae
Prepare a master mix of reagents for all amplification reac-
tions of the series. It should contain the following ingre-
dients per 50-μl reaction:
1  μl dNTP mix (2 mM each), 1 μl forward primer
201CHOMP + 1 μl reverse primer TRACH269 or
PNEUM268 (20 pmol/μl each) OR 1 μl forward primer
204PECOR or 218PSITT + 1 μl reverse primer
CHOMP336s (20 pmol/μl each), 5 μl reaction buffer
(10×), 0.2 μl Taq DNA polymerase (5 U/μl), 40.8 μl H2O.
Add 1 μl of the product from genus-specific PCR as tem-
plate to each reaction vessel.
Subject the products of positive control and negative con-
trol 1 (1 μl of each) from the previous amplification to the
second round of nested PCR. Additionally include a fresh
reagent control (negative control 2). Run PCR according
to the following temperature-time profile: Initial denatur-
ation at 95°C for 30 s, 20 cycles of denaturation (95°C for
30 s), primer annealing (60°C for 30 s) and primer exten-
sion (72°C for 30 s). The correct sizes of species-specific
amplicons are 250 bp for C. trachomatis, 244 bp for C.
pneumoniae, 389–404 bp for C. psittaci, and 426–441 bp
for C. pecorum.
DNA sequencing
For species identification, products of the first PCR round
were amplified using primers 201CHOMP and
CHOMP336s. Specific bands from PCR products were cut
out of the agarose gel (1%) and DNA was extracted usingRespiratory Research 2008, 9:14 http://respiratory-research.com/content/9/1/14
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the QIAquick Gel Extraction Kit (QIAGEN, Hilden, Ger-
many). Prior to processing on the ABI PRISM 310 Genetic
Analyzer (Applied Biosystems), these extracts were sub-
jected to cycle sequencing using the same primers as
above and the BigDye™ Terminator Cycle Sequencing
Ready Reaction Kit (Applied Biosystems, Darmstadt, Ger-
many). The average length of the sequences determined
was 400 nucleotides. The species identity was established
through BLAST search [18]. Sequence alignments and
analysis were conducted using the Vector NTI Suite 8.0
software package (Informax Inc., Oxford, UK).
Statistical analysis
Statistical analysis was done using SPSS, version 12 (SPSS
Inc., Chicago, USA). The data were statistically evaluated
using Mann-Whitney-U-test, Pearson Chi Square test and
Spearman-Rho correlation (2-sided). A test value below
0.05 was considered to be statistically significant.
Results
Clinical data
As a result of the standardized questionnaire and histol-
ogy 45 out of a total of 948 horses were recruited for the
present study. 43 animals were slaughtered and 2 eutha-
nized. The median age was 16.11 years (span: 9–25),
among these were 23 mares, 20 geldings and 2 stallions.
Concerning the respiratory system, 20 animals were con-
sidered clinically as healthy, whereas 25 showed clinical
symptoms of RAO (Table 1). Lameness was the main
cause to kill the horses (40% in both groups). In horses
with RAO, this disease was the reason for killing the ani-
mal in 36%; a respective therapy was applied in 56%.
Therapeutic regimens differed widely, thus not allowing
further statistically evaluation. The majority of horses
both in the clinically healthy and the RAO groups were
housed in stables with straw bedding (healthy controls:
75%, RAO: 68%). Outdoor housing was reported in 20%
of the controls and none of the histologically approved
RAO cases. Stable housing with wood shavings or linen
straw was reported in 32% of cases with RAO and 5% of
controls, respectively.
Light microscopy, immunohistochemistry and 
Immunofluorescence
Comparing RAO and healthy horses (Table 1) a signifi-
cantly different histological score (p = 0.010), number of
Chlamydia psittaci (CP) antigen-positive bronchiolar epi-
thelial cells (p < 0.001), and percentage of all CP antigen-
positive cells (p < 0.001) were found.
In subgroups II and III the distribution of inclusions and
antigens was typical for persistent chlamydial infections
in IHC: inclusion bodies were only sparsely seen, but anti-
gens were much more frequently found. This was also true
for subgroup 1, but on a much lower level.
Animals which were killed specifically because of RAO (n
= 9) were significantly different in the median number of
CP antigen-positive bronchiolar epithelial cells (83 vs. 42,
p = 0.037) compared to horses which were put down due
to other reasons (n = 36).
Results of clinical data and histological evaluation of the
45 horses led to the classification shown in Table 2. The
four subgroups were significantly different from each
other in their light microscopy histological score (Mann-
Whitney U-test, p < 0.05). Age was not significantly corre-
lated to the histological score (Spearman-Rho, p = 0.425).
The clinically healthy horses in subgroup I showed no
(Figure 1) and in subgroup II only slight bronchiolitis. CP
antigens were shown in bronchiolar epithelial cells (Fig-
ures 2, 3 and 4) as well as occasionally in type 2 pneumo-
cytes and macrophages (Figures 4 and 5). Type II
pneumocytes were positive in 12 cases (3 in subgroup I, 1
in subgroup III, 8 in subgroup IV), and in 6 cases positive
staining was also seen in macrophages (1 in subgroup I, 5
in subgroup IV). Data and significant differences are
shown in detail in Table 2. With increased severity of dis-
Table 1: Findings in clinically healthy versus clinically sick horses
n Histological 
score: median 
(span)
IHC (MP): 
median 
(span)
IHC (PII): 
median 
(span)
IHC (BE): 
median 
(span)
IHC 
(percentage): 
median (span)
PCR: positive 
cases 
(percentage)
Clinically healthy 
(Subgroups I + II)
20 0 (0–6) 0 (0–1) 0 (0–4) 17 (0–119) 1.108 (0–8.92) 9 (45)
Clinically sick 
(Subgroups III + IV)
25 3 (0–29) 0 (0–4) 0 (0–63) 113 (4–535) 7.304 (0.20–37.1) 15 (60)
Mann-Whitney-U 
*Pearson Chi 
Square
p = 0.010 p = 0.079 p = 0.127 p < 0.001 p < 0.001 *p = 0.316
Immunohistochemistry (IHC): Number of CP antigen-positive cells in 3 high power fields
MP: macrophages, PII: type II pneumocytes, BE: bronchiolar epithelial cells
IHC (percentage): Number of all CP antigen-positive cells in 3 high power fields in relation to all cellsRespiratory Research 2008, 9:14 http://respiratory-research.com/content/9/1/14
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ease there was a significant rise in antigen-positive cells.
Age was not significantly correlated with immunohisto-
logical parameters (Spearman Rho, p > 0.05). Positive and
significant Spearman-Rho correlations were found
between all of the following parameters: light microscopy
score, the number of CP antigen-positive macrophages,
type II pneumocytes and bronchiolar epithelial cells.
However, the highest correlation coefficient (r = 0.612)
was found between the number of CP antigen-positive
type II pneumocytes and the number of CP antigen-posi-
tive macrophages, the lowest correlation coefficient found
was r = 0.41 between the number of CP antigen-positive
macrophages and the histological score (Table 3).
To obtain further information about localization of
chlamydial antigens, immunofluorescence testing was
performed in three horses. Multiple typical perinuclear
spots in bronchiolar epithelial cells, macrophages and
granulocytes were seen in 2 horses of subgroup IV (Figures
6 and 7). In horses with RAO, the abundance of chlamy-
dial inclusion bodies (red spots) in bronchiolar epithelial
cells (stained green with an anti-cytokeratin pan anti-
body) and macrophages varies from high (Figure 6) to
low (Figure 7).
Housing with straw contact vs. other bedding or RAO with
therapy vs. without therapy and all combinations of the
parameters histological score, results of immunohisto-
chemistry or PCR, lacked any correlations (Mann-Whit-
ney U-test, p > 0.05).
Polymerase Chain Reaction (PCR) and DNA sequencing
No significant differences were seen between clinically
healthy and sick horses (Table 1). PCR revealed CP DNA
Table 2: Comparison of results after subgrouping horses due to clinical and light microscopic findings
n Histological 
score: median 
(span)
IHC (MP): 
median 
(span)
IHC (PII): 
median 
(span)
IHC (BE): 
median 
(span)
IHC 
(percentage): 
median (span)
PCR: positive 
cases 
(percentage)
Subgroup I 15 0 (0–2) 0 (0–1) 0 (–-4) 6 (–-63) 0.359 (0–4,79) 5 (33.3)
Subgroup II 5 5 (4–6) 0 (0–1) 0 (0–2) 76 (11–119) 4.853 (0.88–8.92) 4 (80)
Subgroup III 16 1 (0–5) 0 (0–1) 0 (0–2) 81.5 (4–474) 6.065 (0.20–25.4) 13 (81.2)
Subgroup IV 9 22 (12–29) 1 (0–4) 22 (0–63) 246 (20–535) 21.024 (1.37–37.1) 2 (22.2)
Mann-Whitney-U 
*exact Fisher test
I vs. II: p < 0.001
I vs. III: p = 0.033
I vs. IV: p < 0.001
II vs. III: p = 0.003
II vs. IV: p = 0.001
III vs. IV: p < 0.001
I vs. II: p = n. s.
I vs. III: p = n. s.
I vs. IV: p = 
0.041
II vs. III: p = n. s.
II vs. IV: p = n. s.
III vs. IV: p = 
0.037
I vs. II: p = n. s.
I vs. III: p = n. s.
I vs. IV: p < 
0.001
II vs. III: p = n. s.
II vs. IV: p = 
0.007
III vs. IV: p < 
0.001
I vs. II: p = 
0.033
I vs. III: p < 
0.001
I vs. IV: p < 
0.001
II vs. III: p = n. s.
II vs. IV: p = 
0.042
III vs. IV: p = 
0.023
I vs. II: p = 0.015
I vs. III: p < 0.001
I vs. IV: p < 0.001
II vs. III: p = n. s.
II vs. IV: p = 0.042
III vs. IV: p = 0.020
I vs. II: p = n. s.*
I vs. III: p = 0.019*
I vs. IV: p = n. s.*
II vs. III: p = n. s.*
II vs. IV: p = n. s.*
III vs. IV: p = 0.009*
Subgroup I: Clinically healthy horses without histological changes of RAO
Subgroup II: Clinically healthy horses with a low inflammation score of 4–6
Subgroup III: Horses with clinical signs of RAO, but without or only slight histological changes and a score of 0–5
Subgroup IV: Horses with symptoms and histological changes of RAO with a score > 10
IHC: Number of CP antigen-positive cells in 3 high power fields
MP: macrophages, PII: type II pneumocytes, BE: bronchiolar epithelial cells
IHC (percentage): number of all CP antigen-positive cells in 3 high power fields in relation to all cells
Table 3: Correlations between histological score and immunohistochemical findings
Correlation coefficients (Spearman-Rho, 2-sided) Histological score IHC (MP) IHC (PII)
IHC (MP) 0.410
p = 0.005
IHC (PII) 0.459
p = 0.002
0.612
p < 0.001
IHC (BE) 0.493
p = 0.001
0.448
p = 0.002
0.495
p = 0.001
IHC: Number of CP antigen-positive cells in 3 high power fields
MP: macrophages, PII: type II pneumocytes, BE: bronchiolar epithelial cellsRespiratory Research 2008, 9:14 http://respiratory-research.com/content/9/1/14
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in 5 of 15 (= 33.3%) horses in subgroup I, 4 of 5 (= 80%)
in subgroup II, 13 of 16 (= 81.2%) in subgroup III and 2
of 9 (= 22.2%) in subgroup IV. Significant differences in
PCR positivity are shown between subgroups I and III as
well as between subgroups III and IV (Table 2).
To confirm the identity of the chlamydial species, DNA
from 22 of the 24 positive samples was sequenced in the
ompA gene region (approximately 400 bp). A BLAST
search of these sequences revealed close to 100% hom-
ology to the species CPP in 9 and CPA in 13 cases. No sig-
nificant differences were found between the four
subgroups (Pearson Chi Square test, p = 0.309).
Immunohistochemistry of equine lung tissue in healthy  horses Figure 1
Immunohistochemistry of equine lung tissue in healthy 
horses. Animal showing no bronchiolitis (original magnifica-
tion 10×).
Immunohistochemistry of equine lung tissue in healthy  horses Figure 2
Immunohistochemistry of equine lung tissue in healthy 
horses. Only occasionally some epithelial cells positive for 
Chlamydia psittaci antigens are detectable (brown staining, 
original magnification 40×).
Immunohistochemistry of equine lung tissue in RAO Figure 3
Immunohistochemistry of equine lung tissue in RAO. In 
RAO, animals with severe bronchiolitis (note the striking 
intraluminal accumulation of neutrophils and macrophages) 
most of the bronchiolar epithelial cells carry CP antigens 
(brown staining, original magnification 20×).
Immunohistochemistry of equine lung tissue in RAO Figure 4
Immunohistochemistry of equine lung tissue in RAO. Also in 
the respiratory bronchioli inflammation is found, chlamydial 
antigens (brown staining) are detectable in epithelial cells and 
macrophages (original magnification 40×).Respiratory Research 2008, 9:14 http://respiratory-research.com/content/9/1/14
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Discussion
One principal characteristic of RAO is the excessive pro-
duction of mucus containing high amounts of neu-
trophils [19]. In human COPD, mucus hypersecretion is a
key event as well, but neutrophils are only dominant in
exacerbations [20]. These exacerbations are mainly associ-
ated with viral and/or bacterial infections [21]. In equine
RAO, high levels of collagenolytic activity [22] and matrix
metalloproteinases (MMPs) 8, 9 and 13 [22-25] were
found to be useful markers for ongoing disease. The
release of matrix metalloproteinases (MMP-9) is shown to
be stimulated by chlamydial heat shock protein 60 [26].
Release of MMPs is also crucial for tissue destruction by
macrophages in human emphysema [27] and increased
activities of MMP-8 and MMP-9 are found in induced spu-
tum of humans with COPD [28]. Elevated IL-8 and tumor
necrosis factor-alpha production are seen in horses with
RAO exacerbation [19,29] and in humans with COPD
[30]. The proinflammatory granulocyte-attracting chem-
okine IL-8 is produced by epithelial cells in the course of
infection with CPP [31]. Decreased phagocytic activity of
alveolar macrophages (MP) is found in RAO after 24 h
stimulation with LPS or PMA and ionomycin [19]. In cur-
rent non-smokers with COPD MP show reduced capacity
to ingest apoptotic airway epithelial cells as well [32].
Both RAO and COPD have to be regarded as multicausal
diseases with abiotic and biotic factors. The main etiolog-
ically relevant factor in both RAO and COPD is an exter-
nal event (abiotic factor), i.e. environmental dust
exposure in horses and cigarette smoking in human
beings. Optimal housing can certainly prevent equine
RAO in many cases as well as avoidance of smoking will
prevent COPD. Some authors even regard human COPD
as a dust-induced disease and emphasize the role of kao-
linite [33]. Genetic (biotic) factors are relevant in RAO
[34] and COPD as well [35].
Immunohistochemistry of equine lung tissue in RAO Figure 5
Immunohistochemistry of equine lung tissue in RAO. Prolif-
erating type II pneumocytes show chlamydial antigens as well 
(brown staining, original magnification 40×).
Immunofluorescence of equine lung tissue in RAO Figure 6
Immunofluorescence of equine lung tissue in RAO. In horses 
with RAO, the abundance of chlamydial inclusion bodies (red 
spots) in bronchiolar epithelial cells (stained green with an 
anti-cytokeratin pan antibody) and macrophages varies from 
high to low (compare Figure 7) (original magnification 40×).
Immunofluorescence of equine lung tissue in RAO Figure 7
Immunofluorescence of equine lung tissue in RAO. In horses 
with RAO, the abundance of chlamydial inclusion bodies (red 
spots) in bronchiolar epithelial cells (stained green with an 
anti-cytokeratin pan antibody) and macrophages varies from 
high (compare Figure 6) to low (original magnification 40×).Respiratory Research 2008, 9:14 http://respiratory-research.com/content/9/1/14
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According to the findings of the present study the pre-
dominant location for chlamydial antigens in horse lungs
are the bronchial epithelial cells, followed to a much
lesser extent by type II pneumocytes and macrophages.
For bronchiolar epithelial cells as well as for the total per-
centage of CP antigen-positive cells, there is a highly sig-
nificant higher antigen load in RAO horses in comparison
to healthy controls. Since the first step in the inflamma-
tion cascade is caused by inhalation of dust particles, the
bronchiolar epithelium represents most likely the "key
structure" in establishing and maintaining the disease.
Concurrent infection of these cells with chlamydial organ-
isms might lead to chronicity and persistence of the exag-
gerated inflammatory and tissue destructing response to
dust particles.
Distribution of CP  antigens in the lungs of clinically
healthy horses (subgroups I and II) was typical for persist-
ing infection and in those with RAO and histological
severe disease (subgroup IV) for acute chlamydial infec-
tion. The subgroup with slight inflammation and higher
CP antigen load within the group of healthy horses could
be an indicator of preclinical disease. The same questions
come around according to the subgroups within RAO ani-
mals. Although no significant morphological differences
were seen between healthy horses with slight inflamma-
tion (subgroup II) and those with RAO and low histolog-
ical score (subgroup III) there are severe clinical
differences, which can be interpretated only functionally,
probably on a genetic background.
PCR positivity shows significant differences between sub-
groups I and III as well as between subgroups III and IV.
This means that there is a significant difference also by
PCR between healthy horses and horses that already
present with clinical signs of RAO, but show no or only
slight signs of inflammation and also between ill horses
with only slight inflammation compared with those with
marked inflammation. Furthermore, it is known that
farmers more often suffer from respiratory symptoms
than the average population [36]. Dust exposure and
higher endotoxin concentrations in stables are supposed
to be the main factors [37]. The possible importance of
Chlamydiaceae as a source of human infections in animal
housings requires further evaluation.
Conclusion
For the first time persistence of CPP and CPA in the lungs
of clinically healthy horses and acute (possibly reacti-
vated) chlamydial infections in those with obvious dis-
ease is demonstrated. Respiratory chlamydial infection
probably becomes clinically relevant only in animals
affected by additional pathogenic factors. In this context,
inflammation seems to be associated with the activation
of chlamydiae. Furthermore, the high prevalence of these
chlamydial agents in horse lungs deserves further atten-
tion as a reservoir, especially in the light of recent studies,
showing an association of CPP with cases of equine abor-
tion [14,15]. The possible risk to acquire CPP  or  CPA
infections for the staff in animal housings has to be eval-
uated.
Corresponding pathophysiological aspects (target cell
types, cytokine/chemokine release, tissue degrading
enzymes like MMPs) between chlamydial infections on
the one hand and RAO/COPD on the other hand are
shown. The precise role of chlamydial organisms in the
pathogenesis of RAO/COPD needs further investigations.
Because of the pathophysiological similarities between
both diseases and the detection of Chlamydiaceae, RAO
could be a model for human COPD and should be stud-
ied under these aspects.
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